chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 9/17/2022 Discharge Date: 09/19/2022  PRESENTING PROBLEM: COVID Pneumonia due to COVID-19 virus  Interim hospital course:  Patient hospitalized for COVID-19 pneumonia as well as acute hypoxic respiratory failure.  Patient's hypoxia resolved very quickly following admission, was treated with remdesivir and Decadron.  Patient will be discharged with an additional 7 days of Decadron, will discontinue Remdesivir on discharge.  Echocardiogram done during the patient's stay showing preserved EF of 65% without regional change.  PT recommending home with outpatient therapy which he had already been receiving.  Will be discharged with a walker.  Patient will continue his home medications including inhalers however recommend he hold his home irbesartan given soft blood pressures during his admission and repeat blood pressure check and follow-up with primary care physician 1-2 weeks to assess whether he should resume this medication.
ON 1/5/21 AT 10:00AM, DEVELOPED DIZZINESS THAT LASTED ONE HOUR.
LIghtheaded, nauseous, bloated, dizzy, headache, unwell.
Received vaccine on 7/26/21, symptoms starts 7/31/21. Started feeling more tired then normal and week. Loss of appetite. Rash like on forward and side of face with sores/blisters. Now looking like blood under the skin with open sores and reported itching. Memory lacking more then usual, loss of time.
I was sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE (INFLUENZA SHOT) for prophylaxis.   Previously administered products included Flu shot with an associated reaction of pain in extremity.   On an unknown date, the patient received RSV vaccine and INFLUENZA SHOT. On an unknown date, 1 day after receiving RSV vaccine, the patient experienced sickness (Verbatim: I was sick). The outcome of the sickness was not reported.   The reporter considered the sickness to be possibly related to RSV vaccine.     The company considered the sickness to be possibly related to RSV vaccine.  Additional Information: GSK Receipt Date: 30-SEP-2023 This case was reported by a patient via interactive digital media. The patient got RSV and Flu shot and was sick the next day. The patient thought it was RSV. The patient never got sick with the flu shot accept a sore arm. It was unknown if the reporter considered the sickness to be related to the Flu shot. The follow-up could not be possible as no contact details were available.
This is a spontaneous report from a contactable customer communicated to a sales representative. A male patient of an unspecified age and ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date at 0.5 ml, single for Protection against Neisseria meningitides serogroup B.  The patient medical history and concomitant medications were not reported.  The patient experienced flu symptoms like chills on an unspecified date with outcome of unknown.
day after shot, high fever 103.3, nausea, couldn't move arm, arm numb.  Went to ER.  Sunday the nausea got better,  Fever broke about 7am Sunday, hard knot in the arm. Boostrix vaccine spot he could tell was the one hurting.  Has had Tetnus vaccination before. No history in state immunization system of which one to find out if contained Pertussis.
2/25 after 10 hours I woke up with a lot of soreness at injection site and 99.3 body temperature; 3:30 99.6 temperature, chills, achy arm; 4:47 100.5 temp; 2/26 5:00 AM: chills, 100.0 temp, nausea.
I shopped at the store for at least 15 minutes.  By the time I got back out to my car, the pain in my arm was substantial, but I figured it was going to be similar to the tetanus shots I have received.  I experienced dizziness within 40 minutes and had to cut my errands short.  I had more pain, anxiety, horrible chills, nausea, joint pain in the left arm bones including shoulder and elbow joints.  I had weakness in both hands and some tingling in both hands.  I had weakness in the left arm.  The worst part, my lymph nodes became swollen and painful within 15 hours and remained that way for 2 days with nothing giving relief, including Advil and a heating pad.  Headache and chills occurred all day on Tuesday.  Tuesday evening into Wednesday morning, I sweat profusely in bed and woke up every hour.
Nausea and vomiting  on day 1 and  2. Bloating and diarrhea on day 3. And 4.
suspected vaccination failure; shingles; painful; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported.  The patient was vaccinated and still got shingles. It was painful but somewhat milder.  This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
2 years between their two shingles shots; This case was reported by a pharmacist and described the occurrence of drug dose administration interval too long in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose on an unknown date, two years before).   On 25th January 2023, the patient received the 2nd dose of Shingrix. On 25th January 2023, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's Comments: An adult female patient received her first dose of Shingrix about two years ago. She received her second dose day before reporting. Nothing else were reported. Additional Supportive Information: The patient received 2nd dose of Shingrix, later than the recommended schedule, which led to lengthening of the vaccination schedule.
Redness around injection site Start 1/11/2021 - current (1/19/2021)
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 11-MAY-2016 and 13-JUN-2016, the patient was vaccinated with improperly stored doses of M-M-R II 0.5 ml injection, lot# L027432, expiry date: 22-JUL-2016 (route and site of administration were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at a temperature of 11.1 degrees Celsius for 1 hour and 36 minutes and also at a temperature of -12.3 degrees Celsius for 1 hour and 33 minutes (excursion dates were not reported). No adverse symptoms were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
little bumps on my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of SKIN MASS (little bumps on my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (little bumps on my arm). At the time of the report, SKIN MASS (little bumps on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided by the reporter. No  concomitant medical  provided by the reporter.   Reporter did not allow further contact
Almost like a panic attack. Heart racing and light headed. Did not contact doctor until today but have not gotten phone call back.
States day of vaccine, March 13, developed fever, severs weakness, fatigue that developed 1 hour after receipt of the vaccine.  Also continues to have insomnia and lack of taste from previous COVID infections.  Reason for call was on 3/23/21 upon awaking had developed itching, swollen, red / hot area at injection site.    Instructed to try palliative remedies and if area continues to show symptoms or worsens over next few days to seek medical attention.   Spoke to client on 3/24/21 states arm "is about the same; my doctor is closed today but I am going to see him tomorrow; it looks like a cellulitis".
I noticed a red rash 11 days after my injection and it was a little itchy. I went to the outpatient clinic associated with the Clinic where my Dr. is located. Temperature and blood pressure were taken. All was in the normal range. The rash was on my right arm a bit below the injection site but didn?t go all the way  down to my elbow. I was told told put cold compresses on the area and use Triacinilone ointment 3 times a day.
Within 2-3 minutes after the injection, he turned bright red from the neck up.  Patient stated that his face felt hot.  His hands were sweaty.  He complained of chest tightness.  The physician assistant who examined the patient heard wheezing in the patient's chest.  Patient states that he is a smoker. Symptoms stated to resolve within 10 mins and when patient left the office 30 minutes later, he stated that he was symptom free.
ARM SWOLLEN; ELBOW SWOLLEN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the patient's experienced arm swollen and elbow swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arm swollen, and elbow swollen. This report was non-serious.
Started 12 hours post-vaccination, low grade fever & chills, body aches, headache, tiredness
That day I woke up hoarse and with a headache and throat. And then I noticed the outbreak on my arms and then on my legs. The first came on my back. And already in the whole body. Two appeared on my face, one on the left palpation and the other on the right eyebrows. Itching, inflammation and pain. I still have hives today, July 7.
17 days after primary SPV, patient developed pruritic erythematous papules and pustules on his lower back.  Over the next 3-4 days, he developed additional papules on his chest, thighs, and arms.  Lesions do not have the appearance of vaccinial lesions.  No other complaints except for URI sx (stuffy nose).  Dx. Non-viral pustulosis Tx. Plan/ Recommendations: 1. Rx for sx relief:  Allegra 180 mg po QD # 30 with no refills. 2. Reinforced education on care of the SPV vaccination to prevent transfer of the Vaccinia virus.   3. In a pre-event setting, this service member should be exempt from all future smallpox vaccinations unless direct exposure occurs.
9hr p/vax pt devel a 2-inch area of redness @ the inj site;pt tx w/duricef & DPH & recovered;
: Approximately 3-4 days my rt arm broke out, was bright pink, sore, hotand swollen and itchy; Approximately 3-4 days my rt arm broke out, was bright pink, sore, hotand swollen and itchy; Approximately 3-4 days my rt arm broke out, was bright pink, sore, hotand swollen and itchy; Approximately 3-4 days my rt arm broke out, was bright pink, sore, hotand swollen and itchy; This is a spontaneous report from a contactable consumer or other non Healthcare Professional (The patient, reported for self).   A 74-years-old female patient received second dose of BNT162B2, ((COMIRNATY), Formulation: Solution for injection, Batch/lot number: EN6203, Expiration date: UNKNOWN), via an unspecified route of administration, administered in Arm Right on 02Feb2021 13:30 as single dose for COVID-19 immunisation.    Medical history included stent placement from an unknown date and unknown if ongoing Other medical history: Heart 3 stents, mastectomy, breast cancer double mastectomy, arthritis from unspecified date and unknown if ongoing. Known allergies (Drug hypersensitivity) includes: flu shots, Statin drugs, codeine, ibuprofens. Patient had earlier received first dose of BNT162B2 on 01Feb2021 (Lot  number: EL3246; Vaccine location: Rt arm) for COVID-19 immunisation. Concomitant medication included ergocalciferol, retinol palmitate (VITAMINS A & D); coenzyme q10 [ubidecarenone] (COENZYME Q10 [UBIDECARENONE]); isosorbide; levothyroxine sodium (SYNTHROID), Losartan all taken for an unspecified indication, start and stop date were not reported.    On 26Feb2021, The patient reported that approximately 3-4 days "my rt arm was bright pink, sore, hot, swollen, itchy". Events were non-serious. Outcome of the events was reported as  recovered on an unspecified date.    No follow-up attempts are possible. No further information is expected.
Woke up Thursday morning 10/15/2020 with severe right calf pain, that hurts to touch and does not get better with rest , tylenol ice or heat. Having trouble putting full weight on right leg. Left calf is starting to feel achy as of Friday 10/16/2020. Will continue to monitor
abnormal ECG/EKG; Feverish; severe tachycardia (160bpm, resting); heart palpitations; lightheadedness; severe headache; confusion; nausea; This is a spontaneous report from a contactable consumer (patient). A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 3 Intramuscular administered in Arm Right on 31Aug2021 16:00 (Lot Number: FC3184) as dose 3 (booster), single (at age of 35-years-old) for covid-19 immunisation. No pregnant at time of vaccination. No other vaccine in four weeks. Medical history included Behcet's, CVID (a primary immune deficiency), RA (seronegative), osteoporosis, known allergies. No covid prior vaccination. Historical Vaccine included the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP7534) on 19Mar2021 13:15 (at age of 35-years-old) administrated in Right arm Covid-19 immunization; the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6202) on 26Feb2021 15:45 (at age of 34-years-old) administrated in Right arm Covid-19 immunization. Concomitant medications were unspecified drugs. On 08Sep2021 00:30, the patient experienced abnormal ECG/EKG (hospitalization), feverish, severe tachycardia (160 bpm, resting), heart palpitations, lightheadedness, severe headache, confusion, nausea. The event clinical course was as follows: Feverish for about a week after booster; the Wed after the booster, 6 days prior, she began experiencing severe tachycardia (160bpm, resting) and heart palpitations along with lightheadedness, severe headache, confusion, nausea, and an increase in fever. She went to urgent care and had an abnormal ECG/EKG and was sent via ambulance to hospital. She has a primary immune deficiency so after her hospital EKGs came back, and her labs came back normal. She was discharged conditionally (no doctor wanted to hospitalize her unnecessarily BC of her high risk of contracting nosocomial infection). It had taken about a month for all symptoms to subside, without medical intervention. The patient underwent lab tests and procedures which included body temperature: increase on 08Sep2021, ECG: abnormal on 08Sep2021, EKG: abnormal on 08Sep2021, heart rate: 160 bpm on 08Sep2021, labs: normal on 08Sep2021, Nasal Swab: negative on 16Sep2021. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment received. Outcome of the events was recovering.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On 06-JUN-2016, the patients were vaccinated with improperly stored doses of VARIVAX, lot # L042266 with expiration date 27-OCT-2017 or lot # reported as M002063 with expiration date 12-JAN-2018 (dose and route of administration were not reported), as a part of immunization series. There was no adverse effect reported. Administered doses of vaccine were stored in a freezer and experienced the temperature excursion of 34.1 degrees Fahrenheit for 13 hours. This is one of several reports received from the same reporter. Additional information has been requested.
Patient had onset of whole-body hives within 6-8 hours after receiving this vaccine. Symptoms were mild and self-resolved without other notable symptoms. He has a history of allergies with allergy symptoms that day, but does not often get hives with this and no other known exposures.
Achy in joints hips back and knees for 4 days, lump in right breast that burns and hurts.
After receiving a flu shot (FLUZONE HD INJ [SANO] Qty: 1ML) I experienced pain in my left shoulder. Shot administered on Oct. 17, 2014. The pain abated but has returned as of Nov. 5, 2014. Pain is restricting movement of my left arm to the vertical when I try to extend. No problem with my hand/fingers/etc.
43 yo smallpox vaccinee who developed some "axillary and supraclavicular" adenopathy ~4 days post vaccination and a mild macular rash on his upper extremities 9-10 days post-vaccination. The lesions were small erythematous macules, ~ 8 total.  No papules or vesicles were noted by the examining physician.  He had no c/o fever or myalgias.  He was otherwise doing well.  The rash improved over the next 24-48 hours and was felt to be consistent with a nonspecific dermatologic reaction.
1 day p/vax pt went to ER w/vomitting & h/a;
This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (didn't feel great on Wednesday), BEDRIDDEN (today he has been bedridden), the first episode of CHILLS (severe chills), MYALGIA (body aches) and the second episode of CHILLS (severe chills) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in December 2020. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced the first episode of CHILLS (severe chills). On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (didn't feel great on Wednesday). On 02-Apr-2021, the patient experienced BEDRIDDEN (today he has been bedridden), MYALGIA (body aches) and the second episode of CHILLS (severe chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Chills and Pain NOS, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (didn't feel great on Wednesday), BEDRIDDEN (today he has been bedridden), MYALGIA (body aches) and the last episode of CHILLS (severe chills) outcome was unknown.   DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: inconclusive (Inconclusive) Inconclusive. No Concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-066238.
Organ pain, increased heart rate (110 resting), armpit lymph node swelling and pain (same side as vaccine), headache, fever, chills, body aches
I did not have an adverse reaction to the vaccine. I started feeling symptoms on 12/06/2023. I was on travel when I got sick and tested positive for COVID-19 12/08/2022. The tour guide gave me something similar to ADVIL to relieve my symptoms. As of today, I am well.
This case was reported by a consumer and described the occurrence of vaccine exposure via breast milk in a infant patient who received FLUARIX TETRA. On 8th October 2014, the patient received FLUARIX TETRA. On 8th October 2014, an unknown time after receiving FLUARIX TETRA, the patient experienced vaccine exposure via breast milk. On an unknown date, the outcome of the vaccine exposure via breast mill was unknown. It was unknown if the reporter considered the vaccine exposure via breast milk to be related to FLUARIX TETRA. Additional information: Patient was nursing infant and received a FLUARIX QUADRIVALENT vaccination.
Pt presents to clinic for 1st COVID vaccine.  Consent signed--on consent form pt check yes to having a serious allergic reaction or anaphylaxis due to food/meds/etc.  When asked, pt states she gets a rash from Penicillin.  Informed pt I will observe her for 30 mins after receiving vaccine.  Vaccine given at 0953.  At 1019, mom informed me that pt's chest and throat were itchy--no rash noted.  Pt states she maybe felt a little SOB.  Spoke with Doctors--gave Benadryl 50mg at 1020.  See vitals in vitals tab above.  At 1025, pt stated she had a headache and still had a itchy throat.  See vitals above.  At 1027, pt stated she felt better, itching in her throat was going away.  Vitals taken at 1030--see vitals above.  At 1031, pt states no more itching on chest or throat.  Denis any SOB.  At 1040, pt reported her face felt itchy.  No rash noted.  See vitals above.  Spoke with Dr--continue to monitor pt.  No need for more meds at this time.  Monitor for another 1-2 hrs.  At 1140, Spoke with mom and pt.  Pt denied any itching and states throat feels ok.  Informed mom to call clinic if anything changes or report to ER if difficulties with breathing.  Mom asked about giving another dose of Benadryl if needed.  Nurse told her she could give another dose if itchiness or rash occur.  See vitals above.  Pt's mom wanted provider be aware of situation.  Mom questioning if pt should receive 2nd dose of COVID vaccine or not.  Task sent to provider to review upon her return.